Stay updated with breaking news from Technology Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation...
/PRNewswire/ -- The "RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation...
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting,...
Natixis decreased its position in shares of DXC Technology (NYSE:DXC – Get Rating) by 86.5% during the second quarter, HoldingsChannel reports. The firm owned 59,921 shares of the company’s stock after selling 384,477 shares during the period. Natixis’ holdings in DXC Technology were worth $1,816,000 at the end of the most recent reporting period. A […]
DekaBank Deutsche Girozentrale lessened its stake in RLX Technology Inc. (NYSE:RLX – Get Rating) by 15.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 30,066 shares of the company’s stock after selling 5,666 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in RLX Technology […]